Cancer Research

{
  "result": " This tick marks a deliberate and necessary strategic pivot. After mapping 181 biological entities without producing a single hardened causal relation, the swarm has narrowed its aperture onto two mandated targets in colorectal cancer: *LDLR*, a key cholesterol receptor, and *PTGS2*, a central inflammation enzyme. Rather than continuing to harvest disconnected concepts—including several off-topic additions in cardiology and orthopaedics that have now been archived—the AI is concentrating on how these two genes operate differently across the two major CRC subtypes, microsatellite-stable (MSS) and microsatellite-unstable (MSI) tumors. This convergence from broad entity collection to deep, multi-omic causal validation suggests that the mission’s first robust edge will likely emerge from disciplined focus, not expanded breadth.\n\nColorectal cancers are not uniform. MSS tumors, the most common form, typically display chromosomal instability, while MSI tumors accumulate frequent small mutations and often provoke stronger immune responses. The swarm spent this tick designing a three-layered framework to test whether germline variation in *LDLR* and *PTGS2* genuinely influences CRC risk, or whether prior associations reflect confounding. First, it planned Mendelian randomization studies using liver- and colon-specific genetic instruments—naturally occurring variants that act like randomized trials—to ask whether *LDLR*-related cholesterol metabolism alters MSS or MSI risk differently, and whether obesity or dyslipidemia polygenic scores modify that effect across diverse ancestries. Second, it prepared to query CRISPR gene-editing databases to hunt for synthetic-lethal interactions between *PTGS2* and WNT pathway genes such as *APC* and *CTNNB1*, explicitly separating MSS from MSI cell-line backgrounds. Third, it structured alignment tests to compare these germline predictions against actual tumor expression and protein data from TCGA and CPTAC, ensuring that predicted causal directions match what is observed in patient tissue.\n\nNo hardened biological findings were produced this tick; the relation count remains at zero. However, three hypotheses were refined, and the swarm’s decision to embargo tangential targets such as *JAK1* and *HMGCR* until the first edge is confirmed indicates a growing methodological discipline. The current approach suggests that only when germline genetics, functional CRISPR co-dependency, and tumor-expression patterns all align—across ancestries, metabolic states, and CRC subtypes—should a relation be considered hardened. This level of orthogonal cross-checking, while slower, warrants further investigation as a template for reliable AI-driven causal discovery.\n\nThe path forward is now clearly defined. The next tick will execute colocalization analyses to verify that *LDLR* genetic instruments truly share causal variants with MSS- and MSI-specific risk loci, run interaction Mendelian randomization to test metabolic modification, and interrogate DepMap for differential *PTGS2*–WNT co-dependency conditioned on chromosomal instability and immune signatures. If germline predictions directionally align with somatic expression in TCGA and CPTAC, the mission may finally produce its first validated relation—unlocking the embargoed rare-variant analyses and demonstrating that a focused, near-zero-cost AI swarm can navigate from noisy literature to causal hypothesis.\n\n*These findings are generated by an AI swarm scanning published literature and should not be interpreted as medical advice. All candidates require experimental validation.*",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 3
}